| Entry |
|
|---|
| Name |
Guanoxabenz (USAN/INN) |
|---|
| Formula |
C8H8Cl2N4O
|
|---|
| Exact mass |
246.0075
|
|---|
| Mol weight |
247.0813
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01739 Peripherally-acting antiadrenergic
|
|---|
| Remark |
|
|---|
| Efficacy |
Antihypertensive |
|---|
| Comment |
Guanidine derivative
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
C02CC Guanidine derivatives
C02CC07 Guanoxabenz
D04398 Guanoxabenz (USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01739 Peripherally-acting antiadrenergic
D04398 Guanoxabenz
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C8x C 13.7900 -16.1700
2 C8x C 13.7900 -17.5700
3 C8x C 14.9800 -18.2700
4 C8y C 16.2400 -17.5700
5 C8y C 16.2400 -16.1700
6 C8y C 14.9800 -15.4700
7 X Cl 14.9800 -14.0700
8 X Cl 17.4300 -18.2700
9 C2b C 17.4300 -15.4700
10 N2b N 18.6900 -16.1700
11 N1b N 19.8800 -15.4700
12 C2c C 21.0700 -16.1000
13 N1b N 22.2600 -15.4700
14 O1b O 23.4500 -16.1000
15 N2a N 21.0700 -17.5000
BOND 15
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 4 8 1
9 5 9 1
10 9 10 2
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 12 15 2
|
|---|
